Sunday, November 9, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Waters Stock: Soars on Strong Earnings and Bold Acquisition

Felix Baarz by Felix Baarz
August 4, 2025
in Stocks
0
Waters Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Waters Corporation’s stock surged 3% premarket to $299 following better-than-expected Q2 results and a transformative billion-dollar acquisition announcement. The analytical instruments specialist reported revenue of $771 million, a 9% year-over-year increase, surpassing forecasts, while adjusted earnings per share rose 12% to $2.95. Recurring revenue grew 11%, with strong performance in pharmaceuticals—particularly in China, where sales jumped 14%—driven by demand for GLP-1 therapies and PFAS testing. The company also revealed plans to acquire BD Biosciences & Diagnostic Solutions, projecting $200 million in cost synergies by year three and $290 million in additional revenue by year five, with immediate EPS accretion.

Raised Guidance Reflects Confidence

Buoyed by robust pharma-sector demand and the BD deal, Waters raised its 2025 outlook, forecasting 5.5%–7.5% constant-currency revenue growth and EPS of $12.95–$13.05, up 10% year-over-year. Q3 EPS is expected at $3.15–$3.25. The acquisition positions Waters to dominate in microbiology and mass spectrometry, tapping into a fast-growing $500 million market. Investors responded positively, signaling renewed faith in the company’s growth trajectory.

Ad

Waters Stock: Buy or Sell?! New Waters Analysis from November 9 delivers the answer:

The latest Waters figures speak for themselves: Urgent action needed for Waters investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 9.

Waters: Buy or sell? Read more here...

Tags: Waters
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Lindblad Expeditions Stock

Lindblad Expeditions Stock: Soaring on Record Earnings and Bookings

UBS Stock

UBS Stock: $300M Settlement Rattles Investors

ON Semiconductor Stock

ON Semiconductor Stock: Margins Squeeze Sparks Selloff

Recommended

Healthcare Services Stock Exchange

Keybanc Analyst Initiates Coverage on ResMed with Overweight Rating and Revised Price Target

2 years ago
Biotechnology Market Capitalization

Tyra Biosciences Inc Secures 200 Million in Private Placement Financing

2 years ago
Coherent Stock

Coherent’s Strategic Moves: Financial Reinforcement and Tech Innovation

1 month ago
Celanese Stock

Celanese Shares Plummet Following Major Restructuring Announcement

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Matthews International Faces Critical Earnings Test Amid Stock Slump

Vivani Medical Shares Poised for Potential Breakout

Stereotaxis Stock: A Critical Juncture Approaches

Perma Fix Faces Critical Earnings Test Amid Market Uncertainty

Intellia Therapeutics Shares Plunge Following Clinical Trial Fatality

UPS Fleet Grounded Following Fatal Crash

Trending

Red Robin Gourmet Burgers Stock
Consumer & Luxury

Red Robin’s Pivotal Earnings Report Approaches Amid Restructuring

by Dieter Jaworski
November 9, 2025
0

The upcoming week represents a critical juncture for restaurant chain Red Robin Gourmet Burgers. With significant leadership...

Rent the Runway Stock

Rent the Runway Stock: A Lifeline Extended, But Can It Survive?

November 9, 2025
Corcept Therapeutics Stock

Corcept Therapeutics: Navigating Market Turbulence Amid Critical FDA Decisions

November 9, 2025
Matthews Stock

Matthews International Faces Critical Earnings Test Amid Stock Slump

November 9, 2025
Vivani Med.inc.ew Stock

Vivani Medical Shares Poised for Potential Breakout

November 9, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Red Robin’s Pivotal Earnings Report Approaches Amid Restructuring
  • Rent the Runway Stock: A Lifeline Extended, But Can It Survive?
  • Corcept Therapeutics: Navigating Market Turbulence Amid Critical FDA Decisions

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com